FutureChem Co., Ltd.

As of June 30, 2026, FutureChem Co., Ltd. carries a market capitalization of 182.18B, placing it among publicly traded companies globally. Its enterprise value stands at 164.98B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, FutureChem Co., Ltd. has 23.42M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 9.17, and the price-to-book ratio stands at 3.32.

These figures are as of June 30, 2026. The EV/Sales ratio of 8.01 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 164.98B versus a market cap of 182.18B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, FutureChem Co., Ltd. maintains a current ratio of 3.34, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 9.75, indicating elevated leverage, while an interest coverage ratio of -4.58 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, FutureChem Co., Ltd. posted a negative return on equity (ROE) of -20.36, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -15.96, reflecting losses generated across the asset base. The company generates approximately 223.16M in revenue per employee across its workforce of 92.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 9.62 indicates how many times FutureChem Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 22, 2026, FutureChem Co., Ltd.'s stock has declined approximately 54.09% over the past 52 weeks. The 50-day moving average sits at 6,792.10, while the 200-day moving average is 12,391.27.

Over the twelve months ended June 30, 2026, FutureChem Co., Ltd. generated 20.59B in revenue and converted that into -11.14B in net income, yielding earnings per share of -456.85. EBITDA reached -4.77B, while operating income came in at -9.37B.

As of June 30, 2026, FutureChem Co., Ltd. holds 22.77B in cash and equivalents against 5.37B in total debt, resulting in a net debt position of -1.55B. Total book value stands at 54.91B, with working capital of 20.57B providing operational flexibility.

FutureChem Co., Ltd. produced -5.53B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -9.12B in capital expenditures, free cash flow totaled -14.65B - equivalent to -603.53 per share.

Over the twelve months ended June 30, 2026, FutureChem Co., Ltd. posted a gross margin of 27.45, reflecting its pricing power and cost economics. The operating margin of -45.51 and net profit margin of -54.13 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -7.76: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 0.07, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to FutureChem Co., Ltd. shareholders.

FutureChem Co., Ltd.'s most recent stock split took place on September 17, 2026 with a 5:6 split ratio.

As of June 30, 2026, FutureChem Co., Ltd. has an Altman Z-Score of 6.36, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.